KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Revenue (2016 - 2025)

Historic Revenue for Medpace Holdings (MEDP) over the last 11 years, with Q3 2025 value amounting to $659.9 million.

  • Medpace Holdings' Revenue rose 2373.56% to $659.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 billion, marking a year-over-year increase of 1388.34%. This contributed to the annual value of $2.1 billion for FY2024, which is 1183.62% up from last year.
  • Per Medpace Holdings' latest filing, its Revenue stood at $659.9 million for Q3 2025, which was up 2373.56% from $603.3 million recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' Revenue ranged from a high of $659.9 million in Q3 2025 and a low of $260.0 million during Q1 2021
  • Its 5-year average for Revenue is $443.1 million, with a median of $460.9 million in 2023.
  • Per our database at Business Quant, Medpace Holdings' Revenue surged by 3575.6% in 2021 and then soared by 766.21% in 2024.
  • Medpace Holdings' Revenue (Quarter) stood at $308.6 million in 2021, then increased by 27.72% to $394.1 million in 2022, then rose by 26.47% to $498.4 million in 2023, then increased by 7.66% to $536.6 million in 2024, then grew by 22.98% to $659.9 million in 2025.
  • Its Revenue was $659.9 million in Q3 2025, compared to $603.3 million in Q2 2025 and $558.6 million in Q1 2025.